Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin
about
Self-efficacy and adherence to antiviral treatment for chronic hepatitis C.Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence researchAdherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users.Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study.Hepatitis C treatment eligibility and comorbid medical illness in methadone maintenance (MMT) and non-MMT patients: a case-control studyChronic hepatitis C and antiviral treatment regimens: where can psychology contribute?Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients.Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence.Adherence to chronic hepatitis C treatment regimen: first report from a referral center in iran.Adherence to hepatitis C virus therapy and early virologic outcomes.Impact of hepatitis C treatment initiation on adherence to concomitant medications.Adherence in liver transplant recipients.Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients.Impact of alcohol consumption among patients in hepatitis C virus treatment.Pattern and associated factors of anti-hepatitis C virus treatment-induced adverse reactions.Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin.Patient preferences and assessment of likely adherence to hepatitis C virus treatment.Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study.
P2860
Q33774344-B46855C5-D61E-4FB7-A3EF-D8CA6D996E87Q33795847-3297D851-8BD3-4278-AFCF-74E4DBB9F05EQ35008754-72BF2856-5F73-4CF9-9F1F-BCB1634ADE72Q35053344-0D158BBA-0EC4-486F-B0CA-CEA7B677E5A8Q36006322-910EC604-6CF2-42B9-81F6-FA6BE4C84028Q36296251-90086171-D60D-48D3-B04A-B188488DF46FQ36418455-518A1A53-C784-49DB-94DB-D0AD789F317CQ36445942-38D582B2-D1C6-4D3A-8371-7712C25D6AF1Q36990416-3C587021-43F2-4BC3-8930-DB811E740E6BQ37138784-5010B029-1F26-464A-9F23-ECCE85F07B7BQ37157715-DA5E6FD9-5C88-4B69-8C4C-90C23E514EA9Q37626270-9CC27294-7583-4EF0-A36F-8E63D0073F3CQ37850768-9A6D370F-C14A-4858-BB87-DD0A640700B7Q38894961-D41A5405-342A-431E-BA4C-8870629B4D5BQ40116427-A9CFF5DE-394C-4CBC-BD91-4A1916D56FCBQ42245471-7624D1AD-BD5D-4B2D-9CC8-2EF0C27C6055Q42992590-4FF6AB12-8AFA-4F83-8A88-4388350E0377Q42998032-19C2A622-F4E0-42FA-89A4-E646C0E92B4FQ46546968-F4DE38E5-C32B-491E-AED4-2AB52B974BDC
P2860
Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Hepatitis C patients' self-rep ...... lated interferon and ribavirin
@ast
Hepatitis C patients' self-rep ...... lated interferon and ribavirin
@en
type
label
Hepatitis C patients' self-rep ...... lated interferon and ribavirin
@ast
Hepatitis C patients' self-rep ...... lated interferon and ribavirin
@en
prefLabel
Hepatitis C patients' self-rep ...... lated interferon and ribavirin
@ast
Hepatitis C patients' self-rep ...... lated interferon and ribavirin
@en
P2093
P2860
P1476
Hepatitis C patients' self-rep ...... lated interferon and ribavirin
@en
P2093
D A Fishbein
D T Dieterich
G J Wagner
P2860
P304
P356
10.1111/J.1365-2036.2008.03718.X
P407
P577
2008-08-01T00:00:00Z